LIMITATIONS OF SERUM CREATININE LEVEL AND CREATININE CLEARANCE AS FILTRATION MARKERS IN CIRRHOSIS

被引:226
作者
CAREGARO, L [1 ]
MENON, F [1 ]
ANGELI, P [1 ]
AMODIO, P [1 ]
MERKEL, C [1 ]
BORTOLUZZI, A [1 ]
ALBERINO, F [1 ]
GATTA, A [1 ]
机构
[1] UNIV PADUA,DEPT CLIN MED,PADUA,ITALY
关键词
D O I
10.1001/archinte.154.2.201
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Several studies carried out in a limited number of patients demonstrated a wide range of overestimation of glomerular filtration rate (GFR) by serum creatinine level and creatinine clearance (C-cr) in liver disease. Methods: We simultaneously evaluated C-cr, inulin clearance, and predicted GFR calculated from serum creatinine level in 56 cirrhotic patients. Inulin clearance was considered the gold standard for GFR evaluation. Results: The sensitivity of serum creatinine level, predicted GFR, and C-cr in detecting renal failure was 18.5%, 51%, and 74%, respectively. On the basis of inulin clearance, patients were divided into two groups: those with normal GFR (mean, 106 +/- 34 mL/min per 1.73 m(2)) (group 1, 29 patients) and those with reduced GFR (mean, 56 +/- 19 mL/min per 1.73 m(2)) (group 2, 27 patients). Predicted GFR and C-cr were accurate markers of GFR in group 1 patients, while both overestimated GFR by about 50% in group 2 patients. An increased tubular secretion of creatinine accounted for the disparity between C-cr and inulin clearance in these patients. Conclusions: Our results indicate that renal failure is greatly underestimated on the basis of serum creatinine level and C-cr in cirrhotic patients. Clinical implications of this observation include excessive dosage of potentially nephrotoxic drugs and failure to recognize renal impairment induced by such medical treatments as diuretic therapy or paracentesis.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 15 条
[1]   EFFECTS OF ILOPROST, A PROSTACYCLIN ANALOG DERIVATIVE, ON RENAL PLASMA-FLOW, RENAL-FUNCTION, AND RENIN-ALDOSTERONE SYSTEM IN HUMANS [J].
ANGELI, P ;
GATTA, A ;
CAREGARO, L ;
MENON, F ;
SACERDOTI, D ;
MERKEL, C ;
VISONA, A ;
LUISIANI, L ;
PAGNAN, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (02) :211-216
[2]  
ARROYO V, 1991, OXFORD TXB CLIN HEPA, P427
[3]   NUTRITIONAL ASSESSMENT OF THE HOSPITALIZED PATIENT [J].
BLACKBURN, GL ;
THORNTON, PA .
MEDICAL CLINICS OF NORTH AMERICA, 1979, 63 (05) :1103-1115
[4]  
BURGESS E, 1982, RENAL PHYSIOL BIOCH, V5, P27
[5]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[6]  
EPSTEIN M, 1985, BOCKUS GASTROENTEROL, P3138
[7]   INFLUENCE OF RANGE OF RENAL-FUNCTION AND LIVER-DISEASE ON PREDICTABILITY OF CREATININE CLEARANCE [J].
HULL, JH ;
HAK, LJ ;
KOCH, GG ;
WARGIN, WA ;
CHI, SL ;
MATTOCKS, AM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (04) :516-521
[8]   SERUM CREATININE AND RENAL-FUNCTION [J].
LEVEY, AS ;
PERRONE, RD ;
MADIAS, NE .
ANNUAL REVIEW OF MEDICINE, 1988, 39 :465-490
[9]   MEASUREMENT OF RENAL-FUNCTION IN CHRONIC RENAL-DISEASE [J].
LEVEY, AS .
KIDNEY INTERNATIONAL, 1990, 38 (01) :167-184
[10]   DEVELOPMENT OF RENAL IMPAIRMENT IN LAENNECS CIRRHOSIS [J].
MULLANE, JF ;
GLIEDMAN, ML .
ANNALS OF SURGERY, 1971, 174 (06) :892-+